WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

Thermo Fisher Scientific (TMO) Stock Analysis

BUY

TMO Equity Research — BUY — June 2026

← PFEUNH →

Rating date

Jun 25, 2026

46 days ago

Desk view

BUY

5D move

—

Awaiting market data

Peer rank

95p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · TMO

Now I have a comprehensive picture. Here is the analysis.

Desk rating

BUY

Tactical BUY · 12M BUY

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

BUY

Catalysts

  • Momentum is firmly bullish in the near term — MACD and RSI both support a strong recovery trend from the May 2026 lows.
  • Price has broken above the 50-day SMA (~$474), a critical near-term support level. Holding above this level is key to sustaining the rally.
  • The 200-day SMA ($524.70) is the next major test. A decisive break above it would signal a return to a long-term uptrend; failure could lead to a retest of the $450–460 area.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

TMO Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

32 min read

WebserviceX · Agentic Research Desk

TMO Equity Research Note

Published Jun 25, 2026 · Desk view BUY · Generated 2026-06-26T08:27:50Z · Maintained by Walter Vijayakumar · Methodology · Track record

TMO Stock Rating Summary

TMO bias

BUY

Horizon

Short to medium term

TMO key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

TMO catalyst watch

Momentum is firmly bullish in the near term — MACD and RSI both support a strong recovery trend from the May 2026 lows.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

—Awaiting market dataPeer 95p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:25.913024+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+9.54%

Vol (20D ann.)

+40.95%

vs SPY: +10.19%

Close 505.75 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · TMO

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace fd129f1e…

No QC issues recorded.